Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -6.69% | 3.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.69% | 3.14% | |||
| Cost of Revenue | -6.83% | 7.02% | |||
| Gross Profit | -6.61% | 1.25% | |||
| SG&A Expenses | 33.30% | -8.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.99% | -0.56% | |||
| Operating Income | -55.02% | 14.12% | |||
| Income Before Tax | -50.92% | -0.77% | |||
| Income Tax Expenses | -60.15% | -20.41% | |||
| Earnings from Continuing Operations | -48.20% | 7.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.20% | 7.00% | |||
| EBIT | -55.02% | 14.12% | |||
| EBITDA | -43.70% | 10.76% | |||
| EPS Basic | -48.47% | 7.23% | |||
| Normalized Basic EPS | -58.39% | 23.90% | |||
| EPS Diluted | -48.59% | 9.41% | |||
| Normalized Diluted EPS | -58.45% | 24.04% | |||
| Average Basic Shares Outstanding | 0.45% | -0.15% | |||
| Average Diluted Shares Outstanding | 0.58% | -0.24% | |||
| Dividend Per Share | -- | 0.00% | |||
| Payout Ratio | 0.94% | -0.07% | |||